東華大學圖書館 |

Aging, a Pathological Factor in Neurological Injury.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Aging, a Pathological Factor in Neurological Injury./
作者:	Vijikumar, Aruvi.
面頁冊數:	1 online resource (172 pages)
附註:	Source: Dissertations Abstracts International, Volume: 84-10, Section: B.
Contained By:	Dissertations Abstracts International84-10B.
標題:	Veins & arteries. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30361882click for full text (PQDT)
ISBN:	9798377680949

Aging, a Pathological Factor in Neurological Injury.
Vijikumar, Aruvi.

Aging, a Pathological Factor in Neurological Injury. - 1 online resource (172 pages)

Source: Dissertations Abstracts International, Volume: 84-10, Section: B.

Thesis (Ph.D.)--West Virginia University, 2022.

Includes bibliographical references

One of the main reasons for CNS drugs to fail in clinical development is not considering age as a risk factor while studying chronic age-related neurological/neurodegenerative diseases in preclinical studies. We first set out to gain a comprehensive understanding of the impact of age on various aspects (anatomical, immunological, and biochemical) in rodents that play a key role in determining the onset, progression, and evolution of disease severity. With advancing age, the vascular structure and function are compromised which is hypothesized to accelerate cognitive decline. The initial step toward developing novel therapeutics is to characterize the age-related vascular modifications. Utilizing a vessel painting technique, we labelled the surface cortical vessels of young and aged Sprague-Dawley rats and analyzed for classical angiographic features (junctions, lengths, end points, density, etc). We found significant decrease in vascular components while vascular complexity and lacunarity were significantly increased in the aged brain compared to young brain. These age-dependent changes were prominent at the level of right and left middle cerebral artery (MCA) as well as on a global scale. Next, we investigated the changes on the peripheral immune response following lipopolysaccharide (LPS) induced acute systemic inflammation in young and aged Sprague Dawley rats. We observed age-related immunosuppression in the splenic leukocytes indicative of reduced ability of the spleen to retain the immune cells. We also found dysregulated cytokine/chemokine expression in the plasma following LPS stimulation in aged and young animals. Interestingly, we noticed significant increase in circulatory neutrophil population in the aged animals compared to young animals in response to LPS at 24h. Taken together, these studies confirm the presence of age-related modifications in the vasculature as well as immune system suggesting altered response to injury/infection and thus emphasizing the need to utilize age-appropriate models when studying diseases of the elderly. Lastly, we wanted to test the therapeutic effect of a novel agent in case of brain injury model in aged rodents. Previous studies by our lab and others have showed that targeting mitoNEET using NL-1 was neuroprotective following brain injury models. We wanted to investigate if administration of NL-1 could improve functional outcomes following stroke in an aged rodent model of cerebral ischemia reperfusion injury. We found significant decrease in infarct volume and edema index at 24h post stroke. We also saw enhanced survival and reduced behavior deficits. Moreover, we showed improved BBB integrity, reduced oxidative stress and apoptosis at 72h post stroke. Interestingly, PLGA encapsulated NL-1 at 0.25mg/kg (which is 40-fold lesser dose than NL-1 at 10mg/kg) produced better therapeutic effects. Future studies should focus on understanding the mechanism underlying the biology of aging thus enabling the development of novel therapeutic targets for neurological disorders/diseases.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798377680949Subjects--Topical Terms:

3681939
Veins & arteries.
Index Terms--Genre/Form:

542853
Electronic books.

Aging, a Pathological Factor in Neurological Injury.
LDR:04322nmm a2200349K 4500 001 2365766
005 20231218204703.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798377680949
035 $a (MiAaPQ)AAI30361882
035 $a (MiAaPQ)WVirginia12382
035 $a AAI30361882
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Vijikumar, Aruvi. $3 3706637
245 1 0 $a Aging, a Pathological Factor in Neurological Injury.
264 0 $c 2022
300 $a 1 online resource (172 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 84-10, Section: B.
500 $a Advisor: Huber, Jason D.;Geldenhuys, Werner J.
502 $a Thesis (Ph.D.)--West Virginia University, 2022.
504 $a Includes bibliographical references
520 $a One of the main reasons for CNS drugs to fail in clinical development is not considering age as a risk factor while studying chronic age-related neurological/neurodegenerative diseases in preclinical studies. We first set out to gain a comprehensive understanding of the impact of age on various aspects (anatomical, immunological, and biochemical) in rodents that play a key role in determining the onset, progression, and evolution of disease severity. With advancing age, the vascular structure and function are compromised which is hypothesized to accelerate cognitive decline. The initial step toward developing novel therapeutics is to characterize the age-related vascular modifications. Utilizing a vessel painting technique, we labelled the surface cortical vessels of young and aged Sprague-Dawley rats and analyzed for classical angiographic features (junctions, lengths, end points, density, etc). We found significant decrease in vascular components while vascular complexity and lacunarity were significantly increased in the aged brain compared to young brain. These age-dependent changes were prominent at the level of right and left middle cerebral artery (MCA) as well as on a global scale. Next, we investigated the changes on the peripheral immune response following lipopolysaccharide (LPS) induced acute systemic inflammation in young and aged Sprague Dawley rats. We observed age-related immunosuppression in the splenic leukocytes indicative of reduced ability of the spleen to retain the immune cells. We also found dysregulated cytokine/chemokine expression in the plasma following LPS stimulation in aged and young animals. Interestingly, we noticed significant increase in circulatory neutrophil population in the aged animals compared to young animals in response to LPS at 24h. Taken together, these studies confirm the presence of age-related modifications in the vasculature as well as immune system suggesting altered response to injury/infection and thus emphasizing the need to utilize age-appropriate models when studying diseases of the elderly. Lastly, we wanted to test the therapeutic effect of a novel agent in case of brain injury model in aged rodents. Previous studies by our lab and others have showed that targeting mitoNEET using NL-1 was neuroprotective following brain injury models. We wanted to investigate if administration of NL-1 could improve functional outcomes following stroke in an aged rodent model of cerebral ischemia reperfusion injury. We found significant decrease in infarct volume and edema index at 24h post stroke. We also saw enhanced survival and reduced behavior deficits. Moreover, we showed improved BBB integrity, reduced oxidative stress and apoptosis at 72h post stroke. Interestingly, PLGA encapsulated NL-1 at 0.25mg/kg (which is 40-fold lesser dose than NL-1 at 10mg/kg) produced better therapeutic effects. Future studies should focus on understanding the mechanism underlying the biology of aging thus enabling the development of novel therapeutic targets for neurological disorders/diseases.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Veins & arteries. $3 3681939
650 4 $a Amyotrophic lateral sclerosis. $3 1094680
650 4 $a Human immunodeficiency virus--HIV. $3 3564909
650 4 $a Parkinsons disease. $3 3562685
650 4 $a Mortality. $3 533218
650 4 $a Rodents. $3 3686801
650 4 $a Traumatic brain injury. $3 3691422
650 4 $a Chronic illnesses. $3 3550688
650 4 $a Alzheimers disease. $3 3560855
650 4 $a Aging. $3 543123
650 4 $a Medicine. $3 641104
650 4 $a Neurosciences. $3 588700
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0493
690 $a 0564
690 $a 0317
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a West Virginia University. $3 1017532
773 0 $t Dissertations Abstracts International $g 84-10B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30361882 $z click for full text (PQDT)